Chemotherapy and Radiation Following Pancreatic Surgery
Completed · Phase 2
Conditions studied: Pancreatic Cancer
In brief
To describe the overall survival and disease-free survival in pancreatic cancer patients treated with adjuvant chemoradiation with cisplatin, continuous infusion 5FU and interferon alpha followed by gemcitabine. To describe the toxicities associated with adjuvant chemoradiation with cisplatin. 5FU and interferon alfa followed by gemcitabine in patients with pancreatic cancers.
Key facts
- Study ID
- NCT00660270
- Run by
- Washington University School of Medicine
- People needed
- 53
- Starts
- 2002-05-01
- Expected to finish
- 2009-02-01
- Last updated by the study team
- 2013-04-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington University School of Medicine — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.